These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Procuration and identification of bacteria in paraffin-embedded liver tissues of hepatocellular carcinoma by laser-assisted microdissection technique. Tian XF; Fan XG; Zhang Y; Huang Y; Dai H; Ying RS APMIS; 2008 Jan; 116(1):10-5. PubMed ID: 18254774 [TBL] [Abstract][Full Text] [Related]
23. Potential role of Helicobacter pylori in hepatocarcinogenesis. Ito K; Nakamura M; Toda G; Negishi M; Torii A; Ohno T Int J Mol Med; 2004 Feb; 13(2):221-7. PubMed ID: 14719127 [TBL] [Abstract][Full Text] [Related]
24. Histological and histochemical alterations in liver of chronic hepatitis C patients with Helicobacter pylori infection. Sakr SA; Badrah GA; Sheir RA Biomed Pharmacother; 2013 Jun; 67(5):367-74. PubMed ID: 23659901 [TBL] [Abstract][Full Text] [Related]
25. Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Ward JM; Benveniste RE; Fox CH; Battles JK; Gonda MA; Tully JG Am J Pathol; 1996 Feb; 148(2):509-17. PubMed ID: 8579113 [TBL] [Abstract][Full Text] [Related]
26. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381 [TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
28. Helicobacter species and liver diseases: association or causation? Pellicano R; Ménard A; Rizzetto M; Mégraud F Lancet Infect Dis; 2008 Apr; 8(4):254-60. PubMed ID: 18353266 [TBL] [Abstract][Full Text] [Related]
29. DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Abu Al-Soud W; Stenram U; Ljungh A; Tranberg KG; Nilsson HO; Wadström T Dig Liver Dis; 2008 Feb; 40(2):126-31. PubMed ID: 18083084 [TBL] [Abstract][Full Text] [Related]
30. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738 [TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. Spinzi G; Pellicano R; Minoli G; Terreni N; Cutufia MA; Fagoonee S; Rizzetto M; Ponzetto A Panminerva Med; 2001 Jun; 43(2):85-7. PubMed ID: 11449177 [TBL] [Abstract][Full Text] [Related]
32. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E; Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564 [TBL] [Abstract][Full Text] [Related]
33. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dore MP; Realdi G; Mura D; Graham DY; Sepulveda AR Dig Dis Sci; 2002 Jul; 47(7):1638-43. PubMed ID: 12141829 [TBL] [Abstract][Full Text] [Related]
34. [Status of H. pylori infection in the hepatic tissue of patients with hepatocarcinoma]. Chen R; Chen XP; Lin BL; Cao HJ; Lin QQ Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1028-30. PubMed ID: 20501385 [TBL] [Abstract][Full Text] [Related]
35. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. Giannini E; Fasoli A; Botta F; Romagnoli P; Malfatti F; Chiarbonello B; Mamone M; Savarino V; Testa R Dig Dis Sci; 2003 Apr; 48(4):802-8. PubMed ID: 12741475 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489 [TBL] [Abstract][Full Text] [Related]
38. Helicobacter spp. other than Helicobacter pylori. Okoli AS; Menard A; Mendz GL Helicobacter; 2009 Sep; 14 Suppl 1():69-74. PubMed ID: 19712171 [TBL] [Abstract][Full Text] [Related]
39. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
40. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Ward JM; Anver MR; Haines DC; Benveniste RE Am J Pathol; 1994 Oct; 145(4):959-68. PubMed ID: 7943185 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]